Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Prevalence of pulmonary hypertension (PH) and its influence on survival in chronic obstructive pulmonary disease (COPD) are not well studied in the lung allocation score (LAS) era. METHODS: The UNOS database was queried from 2005 to 2013 to identify first-time adult lung transplant candidates with COPD who were tracked from wait list entry date until death or censoring to determine both prevalence and influence of PH. Using right heart catheterization measurements, mild PH was defined as mean pulmonary artery pressure (mPAP) ≥ 25 mmHg and severe ≥ 35 mmHg. RESULTS: Of 1315 COPD candidates not transplanted, 1243 were used for survival analysis using Cox proportional hazards models, and 1010 (mild PH) and 244 (severe PH) were used for propensity score matching, respectively. A total of 52% (652) of subjects had PH mPAP ≥ 25 mmHg. Univariate analysis revealed significant differences in survival for mild PH (HR = 1.769; 95% CI: 1.331, 2.351; p < 0.001) and severe PH (HR = 3.271; 95% CI: 2.311, 4.630; p < 0.001). Kaplan-Meier survival function demonstrated significant disparities for mild PH (Log-rank test: Chi-square1: 15.87, p < 0.0001) and severe PH (Log-rank test: Chi-square1: 50.13, p < 0.0001). Multivariate Cox models identified significant risk for death for mild PH (HR = 1.987; 95% CI: 1.484, 2.662; p < 0.001) and severe PH (HR = 3.432; 95% CI: 2.410, 4.888; p < 0.001). Propensity score matching confirmed increased mortality hazard associated with mild PH (HR = 2.280; 95% CI: 1.425, 3.649; p = 0.001) and severe PH (HR = 7.000; 95% CI: 2.455, 19.957; p < 0.001). CONCLUSIONS: PH is highly prevalent in advanced COPD and associated with a significantly higher risk for mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The OPTN/UNOS registry data demonstrate that Group 3 pulmonary hypertension is common in patients with advanced CF, ILD, and COPD and is associated with increased oxygen requirements and increased mortality.(294–299)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [295]
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Primary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Epidemiology of atrial fibrillation: European perspective
Zoni-Berisso, M., Lercari, F., Carazza, T., & Domenicucci, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s47385 · Cited by 1,273
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 906
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Pulmonary hypertension in COPD
Chaouat, A., Naeije, R., & Weitzenblum, E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00015608 · Cited by 625
Yusen, R. D., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Dipchand, A. I., Dobbels, F., Goldfarb, S. B., Levvey, B. J., Lund, L. H., Meiser, B., et al. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.08.004 · Cited by 523
Thabut, G., Dauriat, G., Stern, J. B., Logeart, D., Levy, A., Marrash-Chahla, R., & Mal, H. (2005) · Chest · doi:10.1378/chest.127.5.1531 · Cited by 494
Research works printed but not linked: 5
- Decramer M, Lancet 2012, 379, 1341
- Battaglia S, 2014, COPD
- O'Keefe KL, 2014, Exp Clin Transpl, 12, 283
- Gologanu D, 2013, Maedica (Buchar), 8, 243
- Ongel EA, 2014, Int J Chron Obstruct Pulmon Dis, 9, 1187
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Balasubramanian, A., Kolb, T. M., Damico, R. L., Hassoun, P. M., McCormack, M. C., & Mathai, S. C. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.047 · Cited by 52
Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions
Siddiqui, F. M., & Diamond, J. M. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000452 · Cited by 54
Lung transplantation for COPD/pulmonary emphysema
Verleden, G. M., & Gottlieb, J. (2023) · European Respiratory Review · doi:10.1183/16000617.0116-2022 · Cited by 45
Acosta, M. F., Abrahamson, M. D., Encinas-Basurto, D., Fineman, J. R., Black, S. M., & Mansour, H. M. (2020) · The AAPS Journal · doi:10.1208/s12248-020-00531-3 · Cited by 32
Self-citation
Metadata
- Authors
- Hayes, D., Black, S. M., Tobias, J. D., Mansour, H. M., & Whitson, B. A.
- Affiliations
- Nationwide Children's Hospital (US)
- The Ohio State University (US)
- University of Arizona (US)
- Corresponding author
- Hayes, Don
- Venue
- COPD: Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2015-08-20
- Volume
- 13
- Issue
- 1
- Pages
- 50-56
- ISSN
- 1541-2555 (ISSN-L)
- 1541-2563
- OpenAlex
- W1919749432
- Cited by
- 34
- References
- 34
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 6 · 2018: 3 · 2017: 3 · 2016: 2
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- COPD Journal of Chronic Obstructive Pulmonary Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- pulmonary hypertension, chronic obstructive pulmonary disease, lung transplantation, lung transplant candidates, survival, mortality risk, lung allocation score, mean pulmonary artery pressure, right heart catheterization, transplant waiting list, propensity score matching, UNOS registry, advanced COPD
- MeSH terms
- Aged, Female, Humans, Hypertension, Pulmonary, Male, Middle Aged, Prognosis, Retrospective Studies, Waiting Lists, Cohort Studies, Prevalence, Survival Rate, Multivariate Analysis, Proportional Hazards Models, Lung Transplantation, Databases, Factual, Pulmonary Disease, Chronic Obstructive, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation. https://app.cochat.ai/papers/10.3109/15412555.2015.1043425
- The paper
- Hayes, D., Black, S. M., Tobias, J. D., Mansour, H. M., & Whitson, B. A. (2016). Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation. COPD: Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.3109/15412555.2015.1043425
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.